Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (91-100 of 213) with videos related to

Pageof 22
Sort By:
The British Journal of Surgery|October 19, 2022
Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studiesBenjamin Clapp, Ray Portela, Ishna Sharma, et al.
Journal of Neuroendocrinology|May 25, 2023
Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomasJennifer J Gile, Patrick W McGarrah, Konstantinos Leventakos, et al.
JCO Precision Oncology|January 8, 2025
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective StudyCody Eslinger, Bobak Seddighzadeh, Claire Yee, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|October 30, 2013
Evaluation of a home-based colorectal cancer screening intervention in a rural stateMary E Charlton, Michelle A Mengeling, Thorvardur R Halfdanarson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR StudyQing H Meng, Thorvardur R Halfdanarson, Joshua A Bornhorst, et al.
The Oncologist|June 3, 2026
Clinicopathologic, Molecular, and Treatment Features of Metastatic and Distantly Recurrent Extramammary Paget Disease: Mayo Clinic ExperienceRiham Suleiman, Ray Guo, Mary E Lohman, et al.
Pancreas|May 3, 2021
Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic ExperienceJennifer J Gile, Alex J Liu, Patrick W McGarrah, et al.
Cancer|July 29, 2010
Obesity adversely affects survival in pancreatic cancer patientsRobert R McWilliams, Martha E Matsumoto, Patrick A Burch, et al.
JTCVS Open|September 9, 2025
Outcomes of surgical management of carcinoid heart disease in patients with primary gonadal neuroendocrine tumorsTedy Sawma, Hartzell V Schaff, Anita Zheng, et al.
Cancer|November 4, 2021
Management recommendations for pancreatic manifestations of von Hippel-Lindau diseaseShachar Laks, Rachel van Leeuwaarde, Dhaval Patel, et al.
Pageof 22

Showing results (91-100 of 213) with videos related to

Sort By:
Pageof 22
The British Journal of Surgery|October 19, 2022
Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studiesBenjamin Clapp, Ray Portela, Ishna Sharma, et al.
Journal of Neuroendocrinology|May 25, 2023
Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomasJennifer J Gile, Patrick W McGarrah, Konstantinos Leventakos, et al.
JCO Precision Oncology|January 8, 2025
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective StudyCody Eslinger, Bobak Seddighzadeh, Claire Yee, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|October 30, 2013
Evaluation of a home-based colorectal cancer screening intervention in a rural stateMary E Charlton, Michelle A Mengeling, Thorvardur R Halfdanarson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR StudyQing H Meng, Thorvardur R Halfdanarson, Joshua A Bornhorst, et al.
The Oncologist|June 3, 2026
Clinicopathologic, Molecular, and Treatment Features of Metastatic and Distantly Recurrent Extramammary Paget Disease: Mayo Clinic ExperienceRiham Suleiman, Ray Guo, Mary E Lohman, et al.
Pancreas|May 3, 2021
Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic ExperienceJennifer J Gile, Alex J Liu, Patrick W McGarrah, et al.
Cancer|July 29, 2010
Obesity adversely affects survival in pancreatic cancer patientsRobert R McWilliams, Martha E Matsumoto, Patrick A Burch, et al.
JTCVS Open|September 9, 2025
Outcomes of surgical management of carcinoid heart disease in patients with primary gonadal neuroendocrine tumorsTedy Sawma, Hartzell V Schaff, Anita Zheng, et al.
Cancer|November 4, 2021
Management recommendations for pancreatic manifestations of von Hippel-Lindau diseaseShachar Laks, Rachel van Leeuwaarde, Dhaval Patel, et al.
Pageof 22